Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
We studied the anti-HCV prevalence in the same period in all the dialysis patients, staff members and blood donors of the same geographical area. In our opinion, the low prevalence (10.26%) in dialysis patients is strictly correlated to the low prevalence (0.46%) in blood donors.